Dr. Moreau on the CASSIOPEIA Trial in Transplant-Eligible Myeloma
August 30th 2019Phillippe Moreau, MD, head, Hematology Department, university professor of clinical hematology, University Hospital of Nantes, France, discusses the phase III CASSIOPEIA trial in transplant-eligible multiple myeloma.
Read More